Senior Member, Epstein Becker Green, Health Care, Life Sciences and Litigation practices

Lynn Shapiro Snyder is a Senior Member of Epstein Becker Green in the Health Care and Life Sciences and Litigation practices in the firm's Washington, DC, office, and she is Strategic Counsel with EBG Advisors, Inc., and National Health Advisors. Ms. Snyder has 40 years of experience at Epstein Becker Green, advising clients about federal, state, and international health law issues, including Medicare, Medicaid, TRICARE, VA, managed care, compliance, privacy, security, FDA, coding, coverage, and payment issues. Her clients include health care providers, payors, pharmaceutical/device manufacturers, and those companies and financial services firms that support the health care industry, including management and separate board representations. She publishes extensively and is a frequent speaker, particularly on topics related to health reform, enterprise risk, and compliance.

Ms. Snyder serves on the firm's Board and Finance Committee. The firm's Health Care and Life Sciences practice is one of the largest health law practices in the United States. She is Chair of the Third-Party Payment Practice Group, which concentrates on legal and regulatory matters arising under third-party payment programs such as Medicare, Medicaid, and TRICARE. Ms. Snyder co-chairs the Health Care Fraud Practice Group that focuses on federal and state fraud issues, including anti-kickback, self-referral, false claims, secondary payor issues, and false billings. She also co-chairs the Health And Employment Law (HEAL) Group, leading the Health Care and Life Sciences practice in its partnership with the firm's national Labor and Employment practice. She also contributes to the HEAL blog. Ms. Snyder also works on matters in the Pharmaceutical Industry Health Regulatory Practice Group and the Managed Care/Integrated Delivery System Practice Group.

Ms. Snyder's experience includes serving as:

  • Strategic Advisor on Medicare, Medicaid, and Private Payer Matters such as coding/coverage/payment issues and new payment methods, such as accountable care, pay for value, and HCPCS/CPT codes;
  • Lead defense counsel for several health care firms, including one of the largest pharmaceutical firms, one of the largest home health service firms, and one of the largest respiratory services firms in connection with significant fraud investigations/settlements with the federal and state governments;
  • Lead health care deal counsel for private equity firms and strategic partners regarding health policy and health regulatory issues for health care firm transactions, including lead health regulatory counsel for the buyout of HCA by three private equity firms;
  • Outside General Counsel for over a decade to the American Managed Care and Review Association (now AHIP), a national trade association for HMOs, PPOs, and UROs.
Follow us on: